VAREX NAMES KATHLEEN L. BARDWELL TO BOARD OF DIRECTORS
SALT LAKE CITY, August 2, 2022 – Varex Imaging Corporation (“Varex”) (Nasdaq: VREX) today announced that Kathleen L. Bardwell has been appointed to the company’s Board of Directors, effective July 29, 2022. Ms. Bardwell is the former Senior Vice President, Regulatory Affairs & Compliance for STERIS Corporation, a leading provider of infection prevention and other procedural products […]
VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER FISCAL YEAR 2022
Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited
financial results for the second quarter of fiscal year 2022.
Varex Imaging at the International Security Expo at Olympia London
Varex Imaging will attend the International Security Expo at Olympia London.
VAREX SCHEDULES THIRD QUARTER FISCAL YEAR 2022 EARNINGS RELEASE AND CONFERENCE CALL
Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the third quarter of fiscal year 2022 following the close of regular trading on Tuesday, August 2, 2022.
Varex Imaging at ECR 2022
Varex Imaging Corporation will attend the 2022 European Congress of Radiology (ECR) in Vienna this summer.
VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2022
Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited
financial results for the second quarter of fiscal year 2022.
VAREX SCHEDULES SECOND QUARTER FISCAL YEAR 2022 EARNINGS RELEASE AND CONFERENCE CALL
Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2022 following the close of regular trading on Tuesday, May 3, 2022.
Varex Imaging at the 34th Control Trade Show
Varex Imaging Corporation will attend the 34th annual Control international trade fair in Stuttgart, Germany
Varex Announces Partial Redemption of Senior Secured Notes
Varex Imaging Corporation today announced the partial redemption of $27 million of its 7.875% senior secured notes due 2027, which represents 10% of the outstanding principal amount of the notes.
Varex to Present at Oppenheimer’s 32nd Annual Healthcare Virtual Investor Conference
Varex Imaging Corporation announced today that it is scheduled to present at Oppenheimer’s 32nd Annual Healthcare virtual investor conference.